Cargando…
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)
BACKGROUND: Esophagogastric adenocarcinoma (EGA) presents a substantial global health challenge as the number of cases continues to rise. The current standard approach for treating localized EGA involves a combination of triplet chemotherapy, which consists of a platinum compound, a fluoropyrimidine...
Autores principales: | Tintelnot, Joseph, Stein, Alexander, Al-Batran, Salah-Eddin, Ettrich, Thomas, Götze, Thorsten, Grün, Barbara, Haag, Georg Martin, Heuer, Vera, Hofheinz, Ralf-Dieter, Homann, Nils, Bröring, Tobias Sebastian, Cruz, Mariana Santos, Kurreck, Annika, Lorenzen, Sylvie, Moosmann, Nicolas, Müller, Christian, Schuler, Markus, Siegler, Gabriele, Binder, Mascha, Gökkurt, Eray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615128/ https://www.ncbi.nlm.nih.gov/pubmed/37909020 http://dx.doi.org/10.3389/fonc.2023.1272175 |
Ejemplares similares
-
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)
por: Tintelnot, Joseph, et al.
Publicado: (2020) -
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
por: Götze, Thorsten O., et al.
Publicado: (2021) -
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI
por: Al-Batran, Salah-Eddin, et al.
Publicado: (2017) -
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial
por: Stocker, G., et al.
Publicado: (2023) -
Aios in coronatijd
por: Maria Greijn, Claudia, et al.
Publicado: (2020)